Filing Details

Accession Number:
0000914760-16-000389
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-18 14:41:47
Reporting Period:
2016-01-06
Filing Date:
2016-03-18
Accepted Time:
2016-03-18 14:41:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
316253 Enzo Biochem Inc ENZ Services-Medical Laboratories (8071) 132866202
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1244745 L Bernard Kasten C/O Enzo Biochem Inc.
527 Madison Avenue
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-01-21 2,500 $4.66 40,282 No 4 S Direct
Common Stock Disposition 2016-03-10 1,857 $4.40 38,425 No 4 S Direct
Common Stock Disposition 2016-03-10 9,720 $4.40 28,705 No 4 S Direct
Common Stock Disposition 2016-03-10 18,651 $3.47 10,054 No 4 S Direct
Common Stock Disposition 2016-03-11 3,100 $4.39 6,954 No 4 S Direct
Common Stock Disposition 2016-03-11 6,954 $4.41 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (to acquire common stock) Acquisiton 2016-01-06 63,291 $0.00 63,291 $4.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
257,455 2017-01-07 2021-01-05 No 4 A Direct
Footnotes
  1. The Reporting Person was granted 63,291 stock options. The options have a five-year term and shall vest in two equal annual tranches, beginning January 7, 2017.